Risk factors for progression of aortic atheroma in stroke and transient ischemic attack patients
Souvik Sen1, Stephen M Oppenheimer, Joao Lima
1Cerebrovascular Program, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Md, USA.
Insights
Elevated homocysteine levels are linked to aortic atheroma progression in stroke patients. Assessing and treating high homocysteine may help slow the advancement of this cardiovascular risk factor.
Area of Science:
- Cardiovascular research
- Neurology
- Vascular medicine
Background:
- Aortic atheroma is a known stroke risk factor with unknown progression factors.
- Hyperhomocysteinemia is implicated in atherosclerosis, including cerebral vasculature.
Purpose of the Study:
- Investigate associations between elevated homocysteine, stroke risk factors, and aortic atheroma progression.
- Determine clinical and risk factor associations of aortic atheroma progression in cerebrovascular disease patients.
Main Methods:
- 78 patients with cerebrovascular disease underwent transesophageal echocardiograms at baseline and 9 months.
- Aortic atheroma was graded; stroke risk factors and treatments were recorded.
- Patients were stratified by aortic atheroma progression status.
Main Results:
- Aortic atheroma progression occurred in 37% of patients, most notably in the aortic arch.
- Elevated homocysteine levels (≥14.0 µmol/L), total anterior cerebral infarct, and large-artery atherosclerosis significantly correlated with progression.
- No baseline atheroma was observed in two-thirds of patients with unchanged atheroma over 9 months.
Conclusions:
- Elevated homocysteine levels are a significant vascular risk factor associated with aortic atheroma progression.
- Stroke and transient ischemic attack patients with aortic atheroma warrant homocysteine assessment.
- Vitamin treatment for elevated homocysteine may help arrest aortic atheroma progression.
Background And Purpose:
Aortic atheroma is an independent risk factor for stroke and undergoes temporal progression. Clinical and risk factor associations of such progression are unknown. Hyperhomocysteinemia has been linked with atherosclerosis, including that in the cerebral vasculature. This study investigated associations between elevated homocysteine levels and other stroke vascular risk factors and the risk of aortic atheroma progression in patients with cerebrovascular disease.
Methods:
Fifty-seven stroke and 21 transient ischemic attack patients underwent multiplanar transesophageal echocardiograms within 1 month of symptom onset and again at 9 months. Aortic atheroma was graded and stratified by use of existing criteria. Stroke risk factors; use of anticoagulant, antiplatelet, and hypolipidemic drugs; and clinical and etiological subtypes of stroke were recorded and compared in patients stratified for the presence or absence of aortic atheroma progression.
Results:
Of the 78, 29 (37%) progressed, 32 (41%) remained unchanged, and 17 (22%) regressed. Progression was most marked at the aortic arch (P=0.005), followed by the ascending segment (P<0.04). In nearly two thirds of the patients in whom aortic atheroma remained unchanged over 9 months, no atheroma was evident on baseline transesophageal echocardiogram. Only homocysteine levels > or =14.0 micromol/L (P=0.02), total anterior cerebral infarct (P=0.02), and large-artery atherosclerosis (P=0.005) significantly correlated with progression.
Conclusions:
Among vascular risk factors, elevated homocysteine levels are associated with aortic atheroma progression. Stroke and transient ischemic attack patients with aortic atheroma should undergo assessment of homocysteine levels, which, if elevated, may be treated with vitamins in an effort to arrest aortic atheroma progression.
Related Concept Videos
Coronary Artery Disease I: Introduction
Atherosclerosis I: Introduction
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Ischemic Stroke l: Introduction
Transient Ischemic Attack l: Introduction


